International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 2 , Pages 402-407 , 1 February 2006

Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma

  • Uri Tabori, M.D.

      Affiliations

    • Pediatric Brain Tumor Program, The Hospital for Sick Children, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Uri Tabori, M.D., The Hospital for Sick Children, Department of Pediatric Hematology/Oncology, 555 University Ave., Toronto, ON M5G1X8, Canada. Tel: (416) 813-8206; Fax: (416) 813-8851
    • ,
  • Lillian Sung, M.D., Ph.D.

      Affiliations

    • Department of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Juliette Hukin, M.D.

      Affiliations

    • Department of Neurology-Oncology, British Columbia’s Children’s Hospital, Vancouver, British Columbia, Canada
    • ,
  • Normand Laperriere, M.D.

      Affiliations

    • Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    • ,
  • Bruce Crooks, M.D.

      Affiliations

    • Department of Hematology/Oncology, IWK Health Centre, Halifax, Nova Scotia, Canada
    • ,
  • Anne-Sophie Carret, M.D.

      Affiliations

    • Department of Hematology/Oncology, Montreal Children’s Hospital, Montreal, Quebec, Canada
    • ,
  • Mariana Silva, M.D.

      Affiliations

    • Department of Hematology/Oncology, Kingston General Hospital, Kingston, Ontario, Canada
    • ,
  • Isaac Odame, M.D.

      Affiliations

    • Department of Hematology/Oncology, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Chris Mpofu, M.D.

      Affiliations

    • Department of Hematology/Oncology, Saskatoon Cancer Center, Saskatoon, Saskatchewan, Canada
    • ,
  • Douglas Strother, M.D.

      Affiliations

    • Departments of Oncology and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    • ,
  • Beverly Wilson, M.D.

      Affiliations

    • Department of Hematology/Oncology, Stollery Children’s Hospital, Edmonton, Alberta, Canada
    • ,
  • Yvan Samson, M.D.

      Affiliations

    • Department of Hematology/Oncology, Centre Hospitalier Universitaire de Quebec, Quebec, Quebec, Canada
    • ,
  • Eric Bouffet, M.D.

      Affiliations

    • Pediatric Brain Tumor Program, The Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Canadian Pediatric Brain Tumor Consortium

Received 4 June 2005 ,Revised 13 July 2005 ,Accepted 16 July 2005.

References 

  1. Bailey CC , Gnekow A , Wellek S , et al.   Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II . Med Pediatr Oncol . 1995;25:166–178
  2. Evans AE , Jenkin RD , Sposto R , et al.   The treatment of medulloblastoma (Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone) . J Neurosurg . 1990;72:572–582
  3. Gentet JC , Doz F , Bouffet E , et al.   Carboplatin and VP 16 in medulloblastoma (A phase II study of the French Society of Pediatric Oncology (SFOP)) . Med Pediatr Oncol . 1994;23:422–427
  4. Kortmann RD , Kuhl J , Timmermann B , et al.   Postoperative neoadjuvant chemotherapy before radiotherapy as compared with immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood (Results of the German prospective randomized trial HIT ’91) . Int J Radiat Oncol Biol Phys . 2000;46:269–279
  5. Packer RJ , Goldwein J , Nicholson HS , et al.   Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy (A Children’s Cancer Group Study) . J Clin Oncol . 1999;17:2127–2136
  6. Zeltzer PM , Boyett JM , Finlay JL , et al.   Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children (Conclusions from the Children’s Cancer Group 921 randomized phase III study) . J Clin Oncol . 1999;17:832–845
  7. Bouffet E , Doz F , Demaille MC , et al.   Improving survival in recurrent medulloblastoma (Earlier detection, better treatment or still an impasse?) . Br J Cancer . 1998;77:1321–1326
  8. Minn AY , Pollock BH , Garzarella L , et al.   Surveillance neuroimaging to detect relapse in childhood brain tumors (A Pediatric Oncology Group study) . J Clin Oncol . 2001;19:4135–4140
  9. Bloom HJ , Bessell EM . Medulloblastoma in adults (A review of 47 patients treated between 1952 and 1981) . Int J Radiat Oncol Biol Phys . 1990;18:763–772
  10. Abacioglu U , Uzel O , Sengoz M , et al.   Medulloblastoma in adults (Treatment results and prognostic factors) . Int J Radiat Oncol Biol Phys . 2002;54:855–860
  11. Carrie C , Lasset C , Alapetite C , et al.   Multivariate analysis of prognostic factors in adult patients with medulloblastoma (Retrospective study of 156 patients) . Cancer . 1994;74:2352–2360
  12. Chan AW , Tarbell NJ , Black PM , et al.   Adult medulloblastoma (Prognostic factors and patterns of relapse) . Neurosurgery . 2000;47:623–631
  13. Greenberg HS , Chamberlain MC , Glantz MJ , et al.   Adult medulloblastoma (Multiagent chemotherapy) . Neuro-oncol . 2001;3:29–34
  14. Kunschner LJ , Kuttesch J , Hess K , et al.   Survival and recurrence factors in adult medulloblastoma (The M.D. Anderson Cancer Center experience from 1978 to 1998) . Neuro-oncol . 2001;3:167–173
  15. McNeil DE , Cote TR , Clegg L , et al.   Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER update. Surveillance Epidemiology and End Results . Med Pediatr Oncol . 2002;39:190–194
  16. Packer RJ , Rood BR , MacDonald TJ . Medulloblastoma (Present concepts of stratification into risk groups) . Pediatr Neurosurg . 2003;39:60–67
  17. Tabori U , Sung L , Hukin J , et al.   Medulloblastoma in the second decade of life: A specific group with respect to toxicity and management: A Canadian Pediatric Brain Tumor Consortium Study . Cancer . 2005;103:1874–1880
  18. Taylor RE , Bailey CC , Robinson K , et al.   Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma (The International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 Study) . J Clin Oncol . 2003;21:1581–1591
  19. Dunkel IJ , Boyett JM , Yates A , et al.  Children’s Cancer Group   High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma . J Clin Oncol . 1998;16:222–228
  20. Kalifa C , Valteau D , Pizer B , et al.   High-dose chemotherapy in childhood brain tumours . Childs Nerv Syst . 1999;15:498–505
  21. Weil MD , Lamborn K , Edwards MS , et al.   Influence of a child’s sex on medulloblastoma outcome . JAMA . 1998;279:1474–1476
  22. Prados MD , Wara W , Edwards MS , et al.   Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy . Pediatr Neurosurg . 1996;25:174–181
  23. Fernandez-Teijeiro A , Betensky RA , Sturla LM , et al.   Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas . J Clin Oncol . 2004;22:994–998
  24. Gajjar A , Hernan R , Kocak M , et al.   Clinical, histopathologic, and molecular markers of prognosis (Toward a new disease risk stratification system for medulloblastoma) . J Clin Oncol . 2004;22:984–993
  25. Sarkar C , Pramanik P , Karak AK , et al.   Are childhood and adult medulloblastomas different? A comparitive study of clinicopathological features, proliferation index and apoptotic index . J Neurooncol . 2002;59:49–61
  26. Kushner BH , Kramer K , Cheung NK . Chronic neuroblastoma . Cancer . 2002;95:1366–1375
  27. Kushner BH , Kramer K , LaQuaglia MP , et al.   Neuroblastoma in adolescents and adults (The Memorial Sloan-Kettering experience) . Med Pediatr Oncol . 2003;41:508–515
  28. Roach M , Brophy N , Cox R , et al.   Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin’s disease . J Clin Oncol . 1990;8:623–629
  29. Yuen AR , Horning SJ . Hodgkin’s disease (Management of first relapse) . Oncology (Huntingt) . 1996;10:233–240 245
  30. Packer RJ , Gajjar A , Vezina LG , et al.   2340cGy of craniospinal radiotherapy (CRST) plus chemotherapy for children with average-risk medulloblastoma (A prospective randomized Childrens Oncology Group study) . (A9961 [Abstract]) Neuro-oncol . 2004;6:387
  31. National Institutes of Health. Pediatric CNS POG trials information. Available at: http://www.clinicaltrials.gov. Accessed September 7, 2005.
  32. Tarbell NJ , Friedman H , Kepner J , et al.   Outcomes for children with high-stage medulloblastoma (Results of the Pediatric Oncology Group 9031) . [Abstract] Int J Radiat Oncol Biol Phys . 2000;48:134

PII: S0360-3016(05)02211-X

doi: 10.1016/j.ijrobp.2005.07.962

International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 2 , Pages 402-407 , 1 February 2006

Article Tools

* Image Usage & Resolution